#IVF Devices and Consumables Market

[healthcare-domain]

Infertility Treatment Market Scope of Current and Future, Key Players Analysis by 2026

According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.

Browse in-depth TOC on "Infertility Treatment Market"

215 – Tables 40 – Figures 255 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43497112

The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years

The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112

COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete.

The fertility rate worldwide is declining steadily owing to various factors, such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This declining fertility rate has led to a significant increase in the demand for infertility treatment products that determine the fertility window in males and females.

The rise in number of fertility clinics to support the market growth during the forecast period.

Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112

Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.

Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others

[rohans18]

Preimplantation Genetic Screening (PGS) Technology Market Growth, Segments, Demand and Forecast to 2029

Global Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Product and Services (Reagents and Consumables, Instruments, Software and Services), End User (Maternity Centers and Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories and Academic Institutes), Test Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, HLA Typing, Other PGT Types), Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Disease, Others) – Industry Trends and Forecast to 2029

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Preimplantation Genetic Screening (PGS) Technology marketing report. The report has a lot to offer to both established and new players in the Preimplantation Genetic Screening (PGS) Technology industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Preimplantation Genetic Screening (PGS) Technology market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Abbott (US)

Hoffmann-La Roche Ltd (Switzerland)

Thermo Fisher Scientific Inc. (US)

QIAGEN (Netherlands)

3M (US)

Bio-Rad Laboratories (US)

Bruker (US)

Hologic Inc. (US)

Merck KGaA (Germany)

Diagnóstica Longwood SL (Chennai)

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-preimplantation-genetic-screening-pgs-technology-market

With the help of credible Preimplantation Genetic Screening (PGS) Technology market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Preimplantation Genetic Screening (PGS) Technology market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Preimplantation Genetic Screening (PGS) Technology Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Saliva Test Devices market

Kirsten Rat Sarcoma (KRAS) market

Topical Use Acne Treatment Market

Gallstone solubilizing agents market

Amylin analog market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com

[medicaldevicesindustrynews]

Why is Europe Biggest In Vitro Fertilization Devices and Consumables Market?

The human birth rate has dropped drastically from 4.979 births per woman in 1960 to 1.432 per woman in 2017, says the World Bank. A number of factors, including women as well as men’s individual health and lifestyle choices, are responsible for this. For instance, women who smoke carry 50% lesser chances of conceiving. Then, there are numerous fertility-related disorders and sexually transmitted diseases (STD), which also play a part. Therefore, to up their chances of having children, people are rapidly going for in vitro fertilization (IVF), which involves fertilizing the egg outside the human body and then transplanting the embryos in the uterus.

These advancements include the usage of imaging systems and associated software to track the development of embryos on the screen, while still inside the incubator. This allows doctors to select the healthy eggs for transplantation, to give people the highest chances of conceiving a child. Another technological development is pre-implantation genetic diagnosis (PGD), which enables the detection of any genetic disorder the embryo has, for timely action, to minimize the chances of the begotten child inheriting it.

Another reason for the robust rise in the demand for IVF devices and consumables in APAC is the growth of fertility tourism. Just like medical tourism, fertility tourism involves people from developed countries coming to developing nations to get the job done. The primary reason behind this is the high cost of artificial insemination procedures in developed countries. For instance, one IVF cycle costs $10,000–$15,000 in North America, whereas in Thailand, is costs merely $6,059, which is why people prefer developing countries to developed ones.

Hence, with some people not able to conceive naturally and others deliberately delaying the process, the requirement for the consumables and devices used in artificial insemination procedures will continue increasing.

[shawnandrew-blog1]

According to a new report published by Allied Market Research, titled, IVF Devices and Consumables Market, by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025," the market was valued at $1,882 million in 2017, and is expected to reach $6,891 million by 2025, growing at a CAGR of 17.6% from 2018 to 2025.

[don-lichterman]

Asia-Pacific IVF Devices and Consumables Market- A Story of Very Rapid Development

Asia-Pacific IVF Devices and Consumables Market- A Story of Very Rapid Development

IVF Devices and Consumables Market Report PORTLAND, OREGON, UNITED STATES, July 28, 2022 /EINPresswire.com/ — Allied Market Research added new research on Asia-Pacific IVF Devices and Consumables Market- Opportunity Analysis and Industry Forecast, 2022–2030. The IVF Devices and Consumables market explores comprehensive study on various segments like size, share, development, innovation, sales…

[tamanna31]

IVF Devices & Consumables Global Industry by Regions, Type & Applications During 2020-2027

IVF Devices & Consumables Market Overview

The report includes basic information along with advanced market statistics of the global IVF Devices & Consumables market. Accurate information about the market dynamics along with future growth prospects are analysed in the report. Recent developments undertaken by major market players along with their strategic moves driving the market are also covered in the report. Data experts analyse the market information and come up with detailed insights revealing operating margins, competitive landscape, key industry trends and the factors impacting the global IVF Devices & Consumables market. The growth rate from 2020-2027 and the risks faced by current manufacturers form a crucial part of the report. Regionally, the report provides elaborate regional market specifics related to the global IVF Devices & Consumables market along with risks which are limiting development.  

Drivers & Risks

In addition to detailed market information, the report examines important factors which are driving the global IVF Devices & Consumables market. A comprehensive analysis of factors such as potential growth, upcoming opportunities together with risks experienced by current manufacturers forms an integral part of the report.

Method of Research

Porter’s Five Forces Model is used for analysing the IVF Devices & Consumables market. SWOT analysis studies the market from 2020-2027 and helps in identifying the strengths and weaknesses along with clear-cut details of the global IVF Devices & Consumables market. The detailed research is divided into two parts, namely, primary & secondary research. Governing factors, along with current global economic trends, are taken into account in the analysis of the global IVF Devices & Consumables market. The analysis helps in highlighting the market drivers, restraints, challenges and opportunities in the market.  

Get a FREE Report Sample with Table of Contents and Figures @ https://www.datalibraryresearch.com/sample-request/ivf-devices-and-consumables-market-2252

Regional Description

Along with a global analysis, the report provides region-specific information for the IVF Devices & Consumables market. The report covers Latin America, Asia Pacific, Middle & East Africa, Europe and North America. In addition, regional market analysis is included in the report, along with recent trends and regional opportunities along with brief but enlightening information.

Key players

Crucial information related to major as well as new players operating in the market, along with recent trends prevailing in the industry are all included in the report. The report also sheds lights on key Industry player profiles along with their contribution in the global IVF Devices & Consumables market. Different strategies undertaken by market players in order to get a competitive advantage over their competitors and increase their global market reach are also studied comprehensively in the report.

IVF Devices & Consumables MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027

1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities

4. Key Insights 4.1. Key Emerging Trends – For Major Countries 4.2. Latest Technological Advancement 4.3. Regulatory Landscape 4.4. Industry SWOT Analysis 4.5. Porters Five Forces Analysis

Continued.................

Browse Complete Report @   https://www.datalibraryresearch.com/reports/ivf-devices-and-consumables-market-2252

About Data Library Research:    

Data Library Research is an market research company that helps to find its passion for helping brands grow, discover, and transform. As a market research company, we take gratification by providing our clients with a detail insights report and data that will genuinely make a difference to the client business. Our mission is just one and very well defined that we want to help our clients to predict their business environment in the market so that they will able to make strategies and make their decision successful.

Our market analyst teams are esoteric with various types of reports in their respective industries. Data Library Research will help you to refine and research on all parameters, and also help to locate the full range of reports. We review the scope and methodology of the reports you choose and give you the in-depth information and advice to ensure the client to make the right purchase decision.

Data Library Research a unique and one-stop solution to all your needs. We are eager to assist you by sharing our knowledge, which will not only help you make the right decisions but also help you to choose the right product and services for it. Once we start with the discussion, we can find new ideas and solutions. We are just one click away, call us or email us and we will get back in touch with you within 24 hours. We will be happy to welcome you to the family.

[healthcare-domain]

Infertility Treatment Market Size, Share | 2026 | MarketsandMarkets

According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.

The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years

The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112

COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.

The rise in number of fertility clinics to support the market growth during the forecast period.

Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112

Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.

Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US).

[reportcrux]

Asia Pacific Single-Cell Analysis Market Size, Trends and Forecast to 2027

Asia Pacific Single-Cell Analysis Market 2021 Report delivers in-depth data on market size, growth rate, share at country, region and segments level to frame strategic business plans and growth strategies for all business needs. The report is comprehensive blend of quantitative revenue data supported by qualitative data such as growth drivers, opportunities, market challenges, SWOT analysis, PEST analysis along with COVID-19 impact on the businesses across the world.

"Asia Pacific Single-Cell Analysis Market" report offers detailed analysis on specific developments in the market and key business strategies implemented by major market players to strengthen their businesses and market share. The report highlights company profiles, competitive landscape along with product benchmarking analysis for key market players.

Complete analysis on value (revenue),) and growth rate data are provided for years 2016 to 2027. Exhaustive key regional and country level trends and growth drivers are analysed to provide granular market analysis. Report demonstrates historic revenue and growth trends data for years 2016 to 2019 and forecast data for the years 2021 to 2027.

Request a Sample PDF of Report @ https://reportcrux.com/request-sample-report/Single-Cell-Analysis-Market

A thorough analysis on market effect factors, market risks, technological progress, consumer buying behaviour is covered along with value chain analysis, upstream and downstream market development trends and price and cost trends for product and raw materials.

Covid-19 impact analysis

Covid-19 impact analysis focuses on analysing pre- and post-pandemic growth trends, short term and long-term industry dynamics across major regions. Covid-19 recovery path analysis gives insights on the major strategies implemented by industries to respond and recover from the economic crisis due to Covid-19 pandemic. Also, SWOT analysis, PESTEL analysis and Porter's Five forces analysis is clear understanding of market growth influencing factors.

The report offers critical market information crucial for business decisions and strategy implementation based on current market trends and scope. The report also adds strategic inputs gained from key opinion leaders and business decision makers in the related industry.

Key Market Players:

Becton,     Dickinson and Company

Danaher     Corporation

Merck     Millipore

Qiagen     N.V.

Thermo     Fisher Scientific, Inc.

General     Electric Company

10x     Genomics

Promega     Corporation

Illumina,     Inc.

Bio-Rad     Laboratories, Inc.

Fluidigm     Corporation

Agilent     Technologies, Inc.

Nanostring     Technologies, Inc.

Tecan     Group Ltd.

Sartorius     AG

Luminex     Corporation

Takara     Bio Inc.

Fluxion     Biosciences

Menarini     Silicon Biosystems

Lumacyte

Others

The report is prepared by thorough primary and secondary research. Secondary data sources include company websites, magazines, press releases, SEC filings, various paid databases and others. Primary research involves interviews with key industry experts, KOLs, major vendors from both supply and demand side.

Are you Looking for Regional Insights / Report Customization? https://reportcrux.com/request-customization/Single-Cell-Analysis-Market

Asia Pacific Single-Cell Analysis market report is segmented as:

By Application

Research     Applications

Cancer

Immunology

Neurology

Stem     Cell

Other     Research Applications (Tissue Regeneration, Drug Discovery, and Research     on Aging)

Medical     Applications

Noninvasive     Prenatal Diagnosis

in     Vitro Fertilization

Circulating     Tumor Cell Detection

By Technique

Flow     Cytometry

Next-generation     Sequencing

Polymerase     Chain Reaction

Microscopy

Mass     Spectrometry

Other     Techniques (Fluorescence In Situ Hybridization (FISH), Capillary     Electrophoresis (CE), Single-Molecule Fluorescence In Situ Hybridization     (smFISH), and Micromanipulation)

By Cell Type

Human     Cells

Animal     Cells

Microbial     Cells

By Product

Consumables

Beads

Microplates

Reagents

Assay     Kits

Immunoassays

Cell-based     Assays

Other     Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials,     Filtration Apparatus, Petri Dishes, Inserts, and Discs)

Instruments

Flow     Cytometers

NGS     Systems

PCR     Instruments

Spectrophotometers

Microscopes

Cell     Counters

HCS     Systems

Microarrays

Other     Instruments (Laser Capture Microdissection (LCM) Systems,     Micromanipulation Devices, and Integrated Fluidic Circuits (IFCs))

By End User

Academic     & Research Laboratories

Biotechnology     & Pharmaceutical Companies

Hospitals     & Diagnostic Laboratories

Cell     Banks & IVF Centers

The regional scope covers value (revenue) data for below mentioned countries and regions:

North     America (U.S., Canada, Rest of North America)

Europe     (UK, Germany, France, Italy, Spain, Rest of Europe)

Asia     Pacific (China, Japan, India, Southeast Asia, Rest of Asia Pacific)

Latin     America (Brazil, Mexico, Rest of Latin America)

Middle     East and Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and     Africa)

Years considered in the report are:

Historic     Years: 2016-2019

Base     Year: 2019

Estimated     Year: 2020

Forecast     Year 2020 to 2027

Key Advantages to purchase Asia Pacific Single-Cell Analysis Market Report:

To     gain complete analysis on market potential, growth and trends data

To     analyse current competitive trends in the market and strategies used by     key players to strengthen their businesses & leading market position

Evaluate     major market challenges and risks and implement solutions or strategies to     mitigate the market risks

To     gain clear understanding of global market scope, potential, growth     influencing drivers, restraints and opportunities

To     perceive future market outlook and growth prospects for strategic business     decisions like geographic or product portfolio expansion

Besides     syndicate reports, we also offer customized research solutions and     consulting services for specific business needs

Key Highlights of Asia Pacific Single-Cell Analysis Market Report:

Granular     analysis of market size estimates in terms of value (revenue), and growth     rate at country and region level for each segment and sub-segment

Current     industry trends and developments shaping the market

Competitive     market share analysis for major market players, pricing and cost analysis     along with product benchmarking

Qualitative     analysis of growth driving factors, opportunities, restraints, market     challenges and risks or threats

Market     attractiveness analysis for each major segment

To     analyse the revenue pockets in the market for stakeholders or major     vendors by categorizing the specific high growth segments

  Browse Full Report Access here: https://reportcrux.com/summary/7145/Single-Cell-Analysis-Market

[technicaldr]

8 impressive medical device startups to watch [2022]

The following 8 companies have caught our eye for their impressive medical devices, from digital health tools to AI-powered diagnostics.

  1. LegWorks

  LegWorks is a medical device company providing quality prosthetic knees and making them affordable to everyone. According to LegWorks, 90% of amputees in developing countries don’t have access to prosthetic devices. CEO Brandon Burke lost his leg above the knee at age 18 and found that he would end up destroying his prosthetic knees and wanted to create a new option. He partnered with Jan Andrysek, chief technology officer, to create their All-Terrain Knee. They also offer other types that are saltwater safe or ones that offer the ability to jog and/or run. The company's goal is to offer prosthetic knees to those people who otherwise wouldn’t be able to and works with nonprofits to distribute its products.

  2. ComeBack Mobility

  Ukraine-based ComeBack Mobility is focused on make it easy for patient care teams to monitor progress throughout the entire rehabilitation process after sustaining a leg injury. The company offers a product called Smart Crutch Tips that measures how much weight a patient puts on their leg while they use crutches to move around. If the patient puts too much weight on their leg, the crutch tips provide instant feedback so that the patient can adjust accordingly. The crutch tips also come with an app where patients can track their weight-bearing progress. With this data, healthcare providers can advise the patient on the best rehabilitation plan so that they heal quickly and correctly. They can also send new rehab advice straight to the patient through the mobile app.

CEO Ilya Popov, the co-founder of ComeBack Mobility, was inspired to create this tool after going through his own injury. He raised the seed round of funding himself during the COVID-19 lockdown and recently gave an interview about maintaining a medical device startup during wartime.

  3. Proov

  Proov’s rapid response progesterone test strips were invented by Dr. Amy Beckley after she experienced three years of infertility, two rounds of IVF, and seven pregnancy losses. She found out her fertility issues were caused by low progesterone and created these test strips to help other women detect their progesterone levels so they could avoid the same issues and long diagnosis process she went through.

The FDA has authorized these tests, which provide women with information that would otherwise be available only through a blood test at their doctor's office. As of December 2021, the FemTech company had raised $9.7 million in Series A funding, according to Crunchbase.

  4. Senzo

  Senzo, a UK-based startup, is developing an amplified lateral flow (ALF) rapid antigen self-test for COVID-19, which the company says it has the same accuracy as PCR tests. In a recent blinded 3rd-party study, the tests were shown to have 100% accuracy. Senzo also has plans to apply the ALF system to other testing requirements in the future, so people around the world can get accuracy previously only found in laboratories.

In July 2022, the company announced a a Pre-Series A round of funding that "will be used to bring the Amplified Lateral Flow (ALF) COVID-19 at-home rapid test through regulatory approval and to market, increase manufacturing capabilities, and advance the development of a range of new tests to significantly improve the diagnosis of the world's most prevalent and deadly diseases."

  5. Polycarbin

  Life sciences use a lot of plastic, between syringes, DNA extraction kits, and more. In fact, over 12 billion pounds of scientific plastic waste is produced each year, according to Polycarbin, and its goal is to put a stop to that. Founded by two friends who left medical school to start the company, Polycarbin remanufactures laboratory equipment, such as pipette tips, from post-consumer lab plastic. The company helps labs reduce carbon emissions and also provides ways to recycle plastic waste. Its mobile app gives scientists data about reducing their waste, lets them schedule recycling pickup, and more. Labs can also order recycled equipment from Polycarbin. In January 2022, it raised $2 million in seed funding, per Crunchbase.

  6. ABLE Human Motion

  ABLE is a Barcelona-based medical device startup and the world’s first manufacturer of robotic exoskeletons, with a goal of improving quality of life for individuals with disabilities. The award-winning startup began by studying the human gait extensively to create a product that allows wheelchair users to stand up, walk, and sit down without any assistance. The battery-powered, 8 kg exoskeleton has parameters for smart device configurations, which can allow for remote monitoring by physical therapists and physicians.

The lower-body exoskeleton is the first home-use product for individuals with lower-limb paralysis. In mid-2021, they obtained ISO 13485 certification for the design, manufacturing, and sales of their exoskeleton. In July 2022, the company announced that their exoskeleton would be available commercially in Europe in 2023.

  7. Garwood Medical Devices

  Garwood Medical is an advanced MedTech startup based in Buffalo, NY, with a mission of improving clinical outcomes for infections and wound healing. Garwood’s products include the BioPrax™, a minimally invasive device designed to prevent biofilm infections on prosthetic knee implants by using electrodes to prevent microbe growth. It was granted Breakthrough Device designation by the FDA in 2019.

Garwood’s Series B round closed in late November 2019 at $3.7 million. These funds added to the September 2016 Series A round, which raised $3.6 million. “We appreciate the confidence and support from our existing and new investors,” says Garwood CEO Wayne Bacon. “Few people other than physicians and impacted patients understand the tremendous suffering and high treatment costs associated with [periprosthetic joint] infections, which strike tens of thousands of Americans per year [and cost] many billions of dollars.” The company plans on starting human clinical trials in 2023.

  8. Parasym Health

  Parasym is a UK-based medical device startup that provides neurostimulation products to improve the quality of life for patients with inflammatory disorders and chronic pain. Its first product uses micro pulses of electrical current to target the vagus nerve through an ear clip electrode. The Parasym Device is currently CE-marked and has been designated a non-significant risk (NSR) by the FDA.

Technical Doctor's insight:

Contact Details : inquiry@technicaldr.com or 877-910-0004 www.technicaldr.com

[sarahbennu01]

The global organic banana market size will grow by USD 277.2 million during 2019-2023. This market report provides a detailed analysis of the market by distribution channel (offline distribution and online distribution) and geography (APAC, Europe, MEA, North America, and South America).

Get Free Sample - http://bit.ly/33pmrn0

[bloggerthrive]

In-vitro Fertilization Devices Market Restraints

Although there have been many improvements made to the IVF treatments, they still have significant prices because they are time-consuming and systematic. The high cost of IVF treatments also serves as a significant In-vitro Fertilization Devices Market growth inhibitor. The government has a number of onerous rules that can be quite challenging to adhere to at times, which also serves to impede the expansion of this sector.

Read More:

https://knackersblogger.blogspot.com/2022/08/in-vitro-fertilization-devices-market.html